e-learning
resources
Vienna 2003
Tuesday 30.09.2003
Management of COPD in primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Comparison of hospitalization risk for Medicaid patients with COPD by medication regimen
K. Rascati, R. Stanford, R. Borker (Austin, Raleigh, United States Of America)
Source:
Annual Congress 2003 - Management of COPD in primary care
Session:
Management of COPD in primary care
Session type:
Oral Presentation
Number:
2432
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Rascati, R. Stanford, R. Borker (Austin, Raleigh, United States Of America). Comparison of hospitalization risk for Medicaid patients with COPD by medication regimen. Eur Respir J 2003; 22: Suppl. 45, 2432
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Impact of home hospitalization on treatment compliance in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 207s
Year: 2001
Preventative care and home treatment in patients at risk of hospitalisation due to exacerbation of COPD.
Source: International Congress 2018 – The many facets of respiratory nursing
Year: 2018
Predictors of mortality in COPD patients after hospitalization due to an exacerbation
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019
Potential use of a COPD ²e-passport² for assessing hospitalization risks during outpatient visits
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
Exacerbation types by COPD severity; risk of hospitalisation by patients not seeking treatment
Source: Eur Respir J 2003; 22: Suppl. 45, 353s
Year: 2003
Cost burden in COPD patients initiating ICS vs. non-ICS maintenance regimens
Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness
Year: 2019
β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Effect of daily azithromycin therapy and adherence on readmission risk in COPD
Source: Eur Respir J, 53 (3) 1801377; 10.1183/13993003.01377-2018
Year: 2019
Evaluation of costs of inhospital treatment of COPD exacerbations
Source: Eur Respir J 2004; 24: Suppl. 48, 64s
Year: 2004
Do cardiovascular drugs reduce exacerbations rates in primary care patients with COPD?
Source: Eur Respir J 2007; 30: Suppl. 51, 126s
Year: 2007
Compliance of COPD patients to their treatment
Source: Eur Respir J 2003; 22: Suppl. 45, 244s
Year: 2003
Predictors of exacerbations requiring hospitalisation in patients with stable COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 177s
Year: 2006
Risk factors for hospitalisation of CAP patients initially treated in an outpatient setting
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009
Hospitalisation of COPD patients due to comorbidity
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008
Impact of definition when assessing the cumulative incidence of exacerbation amongst a cohort of primary care COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004
Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD
Source: Annual Congress 2012 - COPD: risk factors, biomarkers and diagnosis
Year: 2012
Predictors of inhaled corticosteroid therapy in COPD alone compared to COPD with concomitant asthma managed in primary care
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Rehospitalization rates for patients with COPD who require supplemental oxygen therapy following a hospitalization for an exacerbation
Source: Annual Congress 2012 - The latest insights in integrated care
Year: 2012
Trends in the lifetime risk of COPD exacerbation requiring hospitalisation
Source: Eur Respir J 2013; 42: 964-971
Year: 2013
Six months azithromycin treatment in COPD patients with high risk of further exacerbations
Source: International Congress 2017 – Management of COPD
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept